This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
250mg | $945 | Check With Us |
500mg | $1450 | Check With Us |
1g | $2175 | Check With Us |
Cat #: V1691 CAS #: 1152311-62-0 Purity ≥ 98%
Description: Tezacaftor (formerly VX-661; VX661; VX 661; trade name: Symdeko) is a second F508del CFTR corrector with antifibrotic effects and is also one of three components in the fixed-dose combination medication (cocktail: Elexacaftor/tezacaftor/ivacaftor, Trikafta and Kaftrio) used in patients who have cystic fibrosis with a F508del mutation.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 520.5 |
---|---|
Molecular Formula | C26H27F3N2O6 |
CAS No. | 1152311-62-0 |
Storage | -20℃ for 3 years in powder formr |
-80℃ for 2 years in solvent | |
Solubility In Vitro | DMSO: 100 mg/mL (192.1 mM)r |
Water: <1 mg/mLr | |
Ethanol: <1 mg/mL | |
Synonyms | VX-661; Trikafta; VX661; VX 661. |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 1.9212 mL | 9.6061 mL | 19.2123 mL | 38.4246 mL |
5mM | 0.3842 mL | 1.9212 mL | 3.8425 mL | 7.6849 mL |
10mM | 0.1921 mL | 0.9606 mL | 1.9212 mL | 3.8425 mL |
20mM | 0.0961 mL | 0.4803 mL | 0.9606 mL | 1.9212 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.